Connection

Helmut Albrecht to HIV Infections

This is a "connection" page, showing publications Helmut Albrecht has written about HIV Infections.
Connection Strength

3.569
  1. HIV community viral load trends in South Carolina. Int J STD AIDS. 2017 03; 28(3):265-276.
    View in: PubMed
    Score: 0.325
  2. Rural-urban differences in HIV viral loads and progression to AIDS among new HIV cases. South Med J. 2015 Mar; 108(3):180-8.
    View in: PubMed
    Score: 0.296
  3. New HCV treatment paradigms--now also for patients with HIV. J Watch AIDS Clin Care. 2011 May; 23(5):40.
    View in: PubMed
    Score: 0.227
  4. Report from the 17th Conference on Retroviruses and Opportunistic Infections. CCR5 antagonists--out with the old, in with the new? J Watch AIDS Clin Care. 2010 Apr; 22(4):32.
    View in: PubMed
    Score: 0.210
  5. Raltegravir--beauty and the beast. Both the advantages and the limitations of this integrase inhibitor were evident this year. J Watch AIDS Clin Care. 2010 Jan; 22(1):4.
    View in: PubMed
    Score: 0.207
  6. Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. ALTAIR--the end of NRTI-only regimes. J Watch AIDS Clin Care. 2009 Oct; 21(10):82.
    View in: PubMed
    Score: 0.203
  7. Report from the 16th Conference on Retroviruses and Opportunistic Infections. SWITCHMRK: an avoidable raltegravir disaster. J Watch AIDS Clin Care. 2009 Apr; 21(4):30-1.
    View in: PubMed
    Score: 0.196
  8. HIV and community-acquired MRSA. J Watch AIDS Clin Care. 2009 Mar; 21(3):21-3.
    View in: PubMed
    Score: 0.195
  9. Report from the 15th Retrovirus Conference. Durability of new agents for treatment-experienced patients. AIDS Clin Care. 2008 Apr; 20(4):30.
    View in: PubMed
    Score: 0.183
  10. Report from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. When to start HIV treatment in infants. AIDS Clin Care. 2007 Oct; 19(10):82-3.
    View in: PubMed
    Score: 0.177
  11. A click chemistry amplified nanopore assay for ultrasensitive quantification of HIV-1 p24 antigen in clinical samples. Nat Commun. 2022 Nov 11; 13(1):6852.
    View in: PubMed
    Score: 0.126
  12. Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV. J Acquir Immune Defic Syndr. 2022 08 01; 90(4):377-381.
    View in: PubMed
    Score: 0.124
  13. Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet HIV. 2019 06; 6(6):e364-e372.
    View in: PubMed
    Score: 0.099
  14. Cost-Effectiveness Analysis of Early vs Late Diagnosis of HIV-Infected Patients in South Carolina. South Med J. 2018 06; 111(6):355-358.
    View in: PubMed
    Score: 0.093
  15. The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions. J Acquir Immune Defic Syndr. 2017 05 01; 75(1):35-44.
    View in: PubMed
    Score: 0.086
  16. The South Carolina rural-urban HIV continuum of care. AIDS Care. 2017 07; 29(7):817-822.
    View in: PubMed
    Score: 0.084
  17. The South Carolina HIV Cascade of Care. South Med J. 2015 Nov; 108(11):670-4.
    View in: PubMed
    Score: 0.077
  18. Disparities in viral load and CD4 count trends among HIV-infected adults in South Carolina. AIDS Patient Care STDS. 2015 Jan; 29(1):26-32.
    View in: PubMed
    Score: 0.073
  19. Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults. Clin Cardiol. 2014 Sep; 37(9):517-22.
    View in: PubMed
    Score: 0.071
  20. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2013 Nov; 13(11):927-35.
    View in: PubMed
    Score: 0.067
  21. Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011. Metab Syndr Relat Disord. 2013 Dec; 11(6):417-26.
    View in: PubMed
    Score: 0.066
  22. Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009. South Med J. 2011 Feb; 104(2):95-101.
    View in: PubMed
    Score: 0.056
  23. Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner. PLoS One. 2010 Jun 16; 5(6):e11160.
    View in: PubMed
    Score: 0.053
  24. Missed opportunities for early HIV diagnosis in correctional facilities. AIDS Patient Care STDS. 2009 Dec; 23(12):1025-32.
    View in: PubMed
    Score: 0.051
  25. Serial knife stabbings with HIV exposure--implications for post-exposure prophylaxis. J Infect. 2010 Jan; 60(1):76-8.
    View in: PubMed
    Score: 0.051
  26. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J Immunol. 2008 Apr 15; 180(8):5582-92.
    View in: PubMed
    Score: 0.046
  27. Epidemiological characterization of individuals with newly reported HIV infection: South Carolina, 2004-2005. Am J Public Health. 2009 Apr; 99 Suppl 1:S111-7.
    View in: PubMed
    Score: 0.045
  28. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol. 2005 Mar 01; 174(5):2900-9.
    View in: PubMed
    Score: 0.037
  29. Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients. AIDS. 2004 Feb 20; 18(3):393-402.
    View in: PubMed
    Score: 0.034
  30. Risk-based HIV testing in South Carolina health care settings failed to identify the majority of infected individuals. AIDS Patient Care STDS. 2009 May; 23(5):339-45.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.